FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3126925629> ?p ?o ?g. }

• W3126925629 endingPage "226" @default.
• W3126925629 startingPage "218" @default.
• W3126925629 abstract "The threat of antibiotic resistance is an influencing factor in deteriorating public health. Therefore, new antibiotic development is necessary for continued successful treatment of infectious diseases. Cefiderocol is the first licensed injectable siderophore cephalosporin that chemically conjugates a siderophore and cephalosporin. Due to its high stability against various β-lactamases, it is widely used as an effective antibiotic for multidrug-resistant (MDR) gram-negative microorganisms, including Acinetobacter baumannii, Stenotrophomonas maltophilia, Pseudomonas aeruginosa, and Enterobacteriaceae. Cefiderocol blocks microbial cell membrane synthesis. The binding site of cefiderocol is a penicillin-binding protein. Because of its siderophore-like properties, cefiderocol penetrates gram-negative bacterial periplasmic spaces, increasing its stability against β-lactamases. Unlike earlier cephalosporins, the siderophore of the cefiderocol moiety at position C-3 chelates with iron (ferric form) in the host and is then actively transported into the bacterial periplasmic space. This approach is known as a “Trojan horse” and improves cefiderocol stability against efflux pumps as well as porin channel mutations. Modification at the C-3 and C-7 side-chains produces powerful antibacterial properties against MDR gram-negative bacteria. The U.S. Food and Drug Administration (FDA) approved it as a new treatment option for adult patients with complicated urinary tract infection (cUTI) who have limited and no treatment options. Based on these observations, we conclude that cefiderocol is a potent treatment option for prospective bacterial infections. In this review, we summarize the future prospective use of cefiderocol for bacterial infections." @default.
• W3126925629 created "2021-02-15" @default.
• W3126925629 creator A5046448329 @default.
• W3126925629 creator A5067733908 @default.
• W3126925629 date "2020-12-01" @default.
• W3126925629 modified "2023-10-01" @default.
• W3126925629 title "A Novel Antibiotic Agent, Cefiderocol, for Multidrug-Resistant Gram-Negative Bacteria" @default.
• W3126925629 cites W1977418430 @default.
• W3126925629 cites W1997083763 @default.
• W3126925629 cites W1999979510 @default.
• W3126925629 cites W2033877425 @default.
• W3126925629 cites W2080095202 @default.
• W3126925629 cites W2113898837 @default.
• W3126925629 cites W2123677996 @default.
• W3126925629 cites W2127253161 @default.
• W3126925629 cites W2135121603 @default.
• W3126925629 cites W2145975094 @default.
• W3126925629 cites W2169641796 @default.
• W3126925629 cites W2211192799 @default.
• W3126925629 cites W2318497019 @default.
• W3126925629 cites W2322153556 @default.
• W3126925629 cites W2346730904 @default.
• W3126925629 cites W2466109315 @default.
• W3126925629 cites W2527930446 @default.
• W3126925629 cites W2530661320 @default.
• W3126925629 cites W2534162630 @default.
• W3126925629 cites W2554894514 @default.
• W3126925629 cites W2599881574 @default.
• W3126925629 cites W2683046555 @default.
• W3126925629 cites W2683726696 @default.
• W3126925629 cites W2751939257 @default.
• W3126925629 cites W2766395453 @default.
• W3126925629 cites W2767038067 @default.
• W3126925629 cites W2782246563 @default.
• W3126925629 cites W2783331409 @default.
• W3126925629 cites W2796302271 @default.
• W3126925629 cites W2806849503 @default.
• W3126925629 cites W2895765739 @default.
• W3126925629 cites W2898144230 @default.
• W3126925629 cites W2912906332 @default.
• W3126925629 cites W2939510213 @default.
• W3126925629 cites W2944417449 @default.
• W3126925629 cites W2954782621 @default.
• W3126925629 cites W2981734612 @default.
• W3126925629 cites W2987071743 @default.
• W3126925629 cites W2987552683 @default.
• W3126925629 cites W3008901682 @default.
• W3126925629 cites W3013007475 @default.
• W3126925629 cites W3033057767 @default.
• W3126925629 cites W3033680496 @default.
• W3126925629 cites W4211238209 @default.
• W3126925629 doi "https://doi.org/10.4167/jbv.2020.50.4.218" @default.
• W3126925629 hasPublicationYear "2020" @default.
• W3126925629 type Work @default.
• W3126925629 sameAs 3126925629 @default.
• W3126925629 citedByCount "6" @default.
• W3126925629 countsByYear W31269256292022 @default.
• W3126925629 countsByYear W31269256292023 @default.
• W3126925629 crossrefType "journal-article" @default.
• W3126925629 hasAuthorship W3126925629A5046448329 @default.
• W3126925629 hasAuthorship W3126925629A5067733908 @default.
• W3126925629 hasBestOaLocation W31269256291 @default.
• W3126925629 hasConcept C104317684 @default.
• W3126925629 hasConcept C108319773 @default.
• W3126925629 hasConcept C201663137 @default.
• W3126925629 hasConcept C2776315533 @default.
• W3126925629 hasConcept C2776352461 @default.
• W3126925629 hasConcept C2777637488 @default.
• W3126925629 hasConcept C501593827 @default.
• W3126925629 hasConcept C523546767 @default.
• W3126925629 hasConcept C54355233 @default.
• W3126925629 hasConcept C547475151 @default.
• W3126925629 hasConcept C55493867 @default.
• W3126925629 hasConcept C64778159 @default.
• W3126925629 hasConcept C86803240 @default.
• W3126925629 hasConcept C89423630 @default.
• W3126925629 hasConceptScore W3126925629C104317684 @default.
• W3126925629 hasConceptScore W3126925629C108319773 @default.
• W3126925629 hasConceptScore W3126925629C201663137 @default.
• W3126925629 hasConceptScore W3126925629C2776315533 @default.
• W3126925629 hasConceptScore W3126925629C2776352461 @default.
• W3126925629 hasConceptScore W3126925629C2777637488 @default.
• W3126925629 hasConceptScore W3126925629C501593827 @default.
• W3126925629 hasConceptScore W3126925629C523546767 @default.
• W3126925629 hasConceptScore W3126925629C54355233 @default.
• W3126925629 hasConceptScore W3126925629C547475151 @default.
• W3126925629 hasConceptScore W3126925629C55493867 @default.
• W3126925629 hasConceptScore W3126925629C64778159 @default.
• W3126925629 hasConceptScore W3126925629C86803240 @default.
• W3126925629 hasConceptScore W3126925629C89423630 @default.
• W3126925629 hasIssue "4" @default.
• W3126925629 hasLocation W31269256291 @default.
• W3126925629 hasOpenAccess W3126925629 @default.
• W3126925629 hasPrimaryLocation W31269256291 @default.
• W3126925629 hasRelatedWork W2770431582 @default.
• W3126925629 hasRelatedWork W2806849503 @default.
• W3126925629 hasRelatedWork W2897987794 @default.
• W3126925629 hasRelatedWork W2917342690 @default.

• next